Home A Biotech Beatdown From The Biogen Perspective
 

Keywords :   


A Biotech Beatdown From The Biogen Perspective

2015-10-11 02:43:30| Biotech - Topix.net

The company has a $1.2 billion war chest which it can use to buy another company, buy its own shares, or issue a small dividend. I believe the bar is set pretty low for the company for this third quarter and can potentially be a catalyst to drive the stock up in the near future.

Tags: perspective biotech biogen

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
04.11Tropical Depression Eighteen Graphics
04.11Summary for Tropical Depression Eighteen (AT3/AL182024)
04.11Tropical Depression Eighteen Public Advisory Number 4A
04.11Telekom Srbija renews satellite services contract with SES
04.11Remnants of Patty Graphics
04.11Charter video customers down 294,000 in 3Q 2024
04.11Atlantic Tropical Weather Outlook
04.11Eastern North Pacific Tropical Weather Outlook
More »